Upcoming shows
Real News

NOW ON AIR
Now On Air

Story Time

1:00 am 6:00 am



Maga First News

Upcoming Shows

Join The MAGA Network on Discord

0 0

Roger Stone Asks Judge To Dismiss Case, Wants Unredacted Copy Of Mueller Report

Super Male Vitality

Limited Advanced Release

69.95

31.47

The all new and advanced Super Male Vitality formula uses the newest extraction technology with even more powerful concentrations of various herbs and extracts designed to be even stronger.

https://www.infowars.com/wp-content/uploads/2016/02/smv-200.jpg

https://www.infowarsstore.com/super-male-vitality.html?ims=jftqm&utm_campaign=IW+-+SuperMale+-STFA+-+55%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-SuperMale-55%25off-Widget

https://www.infowarsstore.com/super-male-vitality.html?ims=jftqm&utm_campaign=IW+-+SuperMale+-STFA+-+55%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-SuperMale-55%25off-Widget

Super Male Vitality

69.95

31.47

The all new and advanced Super Male Vitality formula uses the newest extraction technology with even more powerful concentrations of various herbs and extracts designed to be even stronger.

https://www.infowars.com/wp-content/uploads/2016/02/smv-200.jpg

https://www.infowarsstore.com/super-male-vitality.html?ims=jftqm&utm_campaign=IW+-+SuperMale+-STFA+-+55%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-SuperMale-55%25off-Widget

https://www.infowarsstore.com/super-male-vitality.html?ims=jftqm&utm_campaign=IW+-+SuperMale+-STFA+-+55%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-SuperMale-55%25off-Widget

Brain Force Plus

39.95

15.98

Flip the switch and supercharge your state of mind with the all-new Brain Force PLUS: 20% more capsules and a critically enhanced formula featuring a brand new ingredient and increased potency* – all for the same low price.

https://www.infowars.com/wp-content/uploads/2016/02/bf-300-1.jpg

https://www.infowarsstore.com/brain-force.html?ims=bnlem&utm_campaign=IW+-+Brain+Force+-STFA+-+60%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-BrainForce-60%25off-Widget

https://www.infowarsstore.com/brain-force.html?ims=bnlem&utm_campaign=IW+-+Brain+Force+-STFA+-+60%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-BrainForce-60%25off-Widget

Brain Force Plus

39.95

15.98

Flip the switch and supercharge your state of mind with the all-new Brain Force PLUS: 20% more capsules and a critically enhanced formula featuring a brand new ingredient and increased potency* – all for the same low price.

https://www.infowars.com/wp-content/uploads/2016/02/bf-300-1.jpg

https://www.infowarsstore.com/brain-force.html?ims=bnlem&utm_campaign=IW+-+Brain+Force+-STFA+-+60%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-BrainForce-60%25off-Widget

https://www.infowarsstore.com/brain-force.html?ims=bnlem&utm_campaign=IW+-+Brain+Force+-STFA+-+60%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-BrainForce-60%25off-Widget

Brain Force Plus

39.95

15.98

Flip the switch and supercharge your state of mind with the all-new Brain Force PLUS: 20% more capsules and a critically enhanced formula featuring a brand new ingredient and increased potency* – all for the same low price.

https://www.infowars.com/wp-content/uploads/2016/02/bf-300-1.jpg

https://www.infowarsstore.com/brain-force.html?ims=bnlem&utm_campaign=IW+-+Brain+Force+-STFA+-+60%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-BrainForce-60%25off-Widget

https://www.infowarsstore.com/brain-force.html?ims=bnlem&utm_campaign=IW+-+Brain+Force+-STFA+-+60%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-BrainForce-60%25off-Widget

Brain Force Plus

39.95

15.98

Flip the switch and supercharge your state of mind with the all-new Brain Force PLUS: 20% more capsules and a critically enhanced formula featuring a brand new ingredient and increased potency* – all for the same low price.

https://www.infowars.com/wp-content/uploads/2016/02/bf-300-1.jpg

https://www.infowarsstore.com/brain-force.html?ims=bnlem&utm_campaign=IW+-+Brain+Force+-STFA+-+60%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-BrainForce-60%25off-Widget

https://www.infowarsstore.com/brain-force.html?ims=bnlem&utm_campaign=IW+-+Brain+Force+-STFA+-+60%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-BrainForce-60%25off-Widget

Source: InfoWars

0 0

Filipinos start evacuating from Libyan capital; 1 wounded

Philippine diplomats say they have started evacuating a small group of Filipinos from the Libyan capital after it was hit by a barrage of rocket fire that wounded one Filipino.

Department of Foreign Affairs spokesman Emmanuel Fernandez said Thursday three hospital workers and four students were evacuated by Philippine Embassy personnel from Tripoli to Tunisia, where they are to take flights back home.

Manila's top diplomat in Tripoli, Elmer Cato, says 13 more Filipinos have sought help and are expected to be flown back home soon.

Cato says that of about 1,000 Filipinos in Tripoli, only 20 have so far asked to be repatriated, including Rolando Torres, who was wounded in the forehead in the rocket fire late Tuesday in the Libyan capital.

Source: Fox News World

0 0

Democratic presidential candidate Gillibrand releases tax returns in challenge to rivals

FILE PHOTO: Democratic 2020 U.S. presidential candidate and U.S. Senator Kirsten Gillibrand (D-NY) speaks during her campaign kick off event in New York
FILE PHOTO: Democratic 2020 U.S. presidential candidate and U.S. Senator Kirsten Gillibrand (D-NY) speaks during her campaign kick off event in New York, New York, U.S., March 24, 2019. REUTERS/Carlo Allegri/File Photo

March 27, 2019

By Amanda Becker

WASHINGTON (Reuters) – Democratic U.S. Senator Kirsten Gillibrand’s presidential campaign on Wednesday released her tax returns for the years 2007 through 2018, offering the most comprehensive look to date at the finances of a 2020 White House candidate’s finances, as she called on her rivals to do the same.

Gillibrand reported about $218,000 in income for the tax year 2018, including $167,634 from her Senate salary and $50,000 from a book deal that was reported as business income, the tax filing shows. Gillibrand’s husband, who in previous years had worked as a financial consultant, reported no income in 2018.

The New York senator paid $29,170 in federal taxes – an effective tax rate of 13.6 percent – and an additional $12,523 in state taxes, according to the 2018 return.

“I want voters to know that I’m beholden to no one, that my values are not for sale and that I’m working only for you,” Gillibrand said in a video released by her campaign.

“Join me in calling on every presidential candidate to disclose their taxes, this is what transparency and accountability is all about.”

Gillibrand’s release of tax filings is a contrast with President Donald Trump, who was the first modern U.S. president not to release his tax returns to the public. Gillibrand, who formally joined the presidential race on March 17, gave a fiery speech on Sunday in which she called Trump a “coward” who “is tearing apart the moral fabric of this country.”

The release of her tax documents indicates Gillibrand, 52, likely will make transparency a theme of her campaign. She is trying to build momentum among a group of more than 15 announced and potential candidates vying for the Democratic nomination, including five other senators and former Vice President Joe Biden, who is expected to join the race soon.

Gillibrand, along with other candidates such as Senators Elizabeth Warren, Bernie Sanders, Cory Booker and Kamala Harris, is trying to position herself as a progressive in race, with many making anti-corruption efforts and getting big money out of politics central to their campaigns.

Warren previously released her tax returns for 2007 through 2017 but not her 2018 filing, which is not due to the Internal Revenue Service until April 15. Sanders, who released one annual tax filing during his 2016 presidential primary campaign, said last month that he will soon release more filings but they “will bore you to death.”

After taking control of the House of Representatives in the 2018 elections, Democrats passed a bill that would require presidential candidates to release their tax returns. It has not been voted on by the Senate, which is controlled by Republicans.

(Reporting By Amanda Becker; Editing by Bill Trott)

Source: OANN

0 0

CDC: Yellow Fever Vaccine Has “Serious Sometimes Fatal Side Effects”

In January, 2019, news outlets reported the death of a leading cancer researcher in the UK, who suffered total organ failure not long after receiving a yellow fever (YF) vaccine.

Both the UK and the U.S. recommend YF vaccination for anyone nine months of age or older who is planning to travel to a yellow-fever-endemic country in sub-Saharan Africa or South America.

Alex Jones exposes the globalist agenda to use government agencies to cover up their crimes against the population.

Public health authorities admit that the YF vaccine—an attenuated live-virus vaccine—can, in “rare” cases, “have serious and sometimes fatal side effects” and that the risks are about four times higher in individuals age 60 or older, but many older travelers continue to be given the vaccine anyway. In the fatal January incident, the deceased scientist was 67 years old; after his death, the medical research institution that employed him instructed The Guardian to amend its news account to say that the death occurred “following,” rather than “as a result of,” yellow fever vaccination.

In the early 2000s, news reporters apparently had a bit more leeway to disclose vaccine risks. A 2001 story about YF-vaccine-related deaths in three countries concluded that the fatalities “underscored yet again that there is no such thing as a perfectly safe vaccine.” A recent search of “yellow fever vaccine adverse events” in PubMed (the National Library of Medicine’s free search engine) pulled up 168 search results for studies published over the past couple of decades. Considering that an estimated 99% of vaccine-related adverse events never even get reported, perhaps it is time to reexamine the yellow fever vaccine’s risks.

Death, Madness and Organ Failure

The UK is no stranger to dramatic stories about YF vaccination gone awry. A former BBC foreign correspondent recently described his journey into psychosis after YF vaccination, noting that others who have contacted him report that they, too, suffered “delusion and hallucinations after having the vaccination.” He received his vaccine in Greece, where, rather unusually, “the doctors…told him they believed he’d had an adverse reaction to the vaccine.” After a difficult period of treatment and eventual recovery, the BBC reporter wrote a book and made a filmabout the “Kafkaesque” experience and is attempting to have the vaccine’s manufacturer, Sanofi Pasteur, “admit liability for what happened to him.” Commenting on the film, one individual stated, “It’s difficult to imagine that [a commonly administered] inoculation against disease…could have an effect so darkly devastating on a human being. Yet here it is, recorded in all the pain, misery and anguish for us all to see.”

As scientists have come to admit that modern YF vaccines can cause “invasive and disseminated disease in…otherwise healthy individuals, with high lethality,” they have coined several terms to describe the phenomenon. The acute multiple organ system dysfunction suffered by the UK cancer researcher is called yellow fever vaccine-associated viscerotropic disease (YEL-AVD). Published studies also report serious side effects such as yellow fever vaccine-associated neurotropic disease (YEL-AND)—for example, meningitis or acute disseminated encephalomyelitis—as well as “immediate hypersensitivity or anaphylactic reactions.” According to a 2012 report coauthored by CDC researchers and others, YEL-AVD is fatal in over 60% of reported cases, with a median of 10 days from vaccination to time of death; severe YEL-AVD is characterized by low blood pressure, “hemorrhage, acute renal failure, and acute respiratory failure.” In 2015, an Oregon woman in her 60s died within nine days of receiving a yellow fever shot after suffering a severe reaction involving heart damage and kidney failure.

The CDC report states that YEL-AVD results from out-of-control “dissemination and replication” of the vaccine-strain virus—with studies having documented vaccine virus “in a number of postmortem tissues obtained from YEL-AVD case patients.” Researchers likewise posit that YEL-AND results from “direct viral invasion of the central nervous system by the vaccine virus” or, in some instances, an autoimmune reaction.

How Many Cases? Who Knows?

As of 2010, an international working group identified 60 reports of YEL-AVD (both published and unpublished) from Asia, Australia, Europe, and North and South America. Conservative estimates based on these reports suggest that there may be 3-4 cases of YEL-AVD per million doses distributed, with 14-18 cases per million doses in individuals 60-plus years old and as many as 117 per million reported in a study involving a single vaccine lot.

However, many factors impede identification and reporting of adverse events following yellow fever (and other) vaccines, including “differences in definitions, surveillance system organisation, methods of reporting cases, administration of [YF vaccine] with other vaccines, incomplete information about denominators, time intervals for reporting events, the degree of passive reporting, access to diagnostic resources, and differences in time periods of reporting.” In a systematic review of studies published through 2016—focusing on cases of YEL-AVD in developed countries—the reviewers identified 62 cases but had insufficient evidence to provide “diagnostic certainty” for another 70 cases and excluded three dozen more cases due to “imprecise” coding. The reviewers then reported being unable to compute an overall rate due to the incomplete information. Combined with the known problem of underreporting of vaccine adverse events, official statistics may significantly underestimate the true incidence of adverse reactions following YF vaccination.

Following World Health Organization (WHO) recommendations, over two dozen countries in Africa and many countries in Latin America and the Caribbean include YF vaccination on their childhood vaccine schedules, generally recommending an initial shot at 9 to 12 months of age and a booster every 10 years. Gavi (the international vaccine alliance led by the Bill & Melinda Gates Foundation, WHO, UNICEF and the World Bank) has been pushing for increased YF vaccine coverage in Africa since 2011. The track record for yellow fever vaccination in Africa is spotty, however—an earlier-generation YF vaccine that was widely administered in francophone Africa was discontinued in 1982 due to “genetic instability” and “high rates of post-vaccination encephalitis in children.” Currently, the occurrence of severe adverse events in Africa is anyone’s guess, because detection of adverse events in low-income countries is particularly time-consuming and resource-intensive. Individuals who suffer reactions may also be less likely to reach health care, making it even less likely that the adverse events will be investigated and published.

Risks Across Age Groups

Although countries like the UK and U.S. warn of YF vaccine risks only for older adults or other vulnerable groups such as immune-compromised individuals, the published literature demonstrates the potential for adverse events in healthy individuals across all age groups. For example:

  • In 2001, The Lancet reported two fatal cases of hemorrhagic fever associated with YF vaccination in a 5-year-old and 22-year-old in Brazil, attributing the deaths to “idiosyncratic” host factors.
  • A 2017 study by Polish researchers reported a case of YF vaccine-associated meningitis in a 39-year-old male “without evidence of significant risk factors.”
  • CDC researchers who analyzed adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) following either primary or secondary yellow fever vaccination (N=938) from 2007 through 2013 ascertained that reactions had occurred in individuals ranging from 5 to 88 years old. They classified 9% of the adverse events as “serious”—including death, anaphylaxis, Guillain-Barré syndrome and organ failure.
  • In 2017, Singapore researchers reported systemic adverse events in over 63% of adults aged 21 to 50 years old who received the YF vaccine; they noted a significant correlation between the vaccine’s stimulation of a potent immune response and the probability of an adverse event.

From Chickens to Tobacco Farming

Some of the earliest attempts to develop vaccines focused on yellow fever (although a vaccine developed in 1901 killed 7% of the volunteers in whom it was tested and sickened another 19%). In the 1930s, vaccine scientists started experimenting with YF vaccines prepared from mouse brain cultures and chicken embryos. YF vaccines are still prepared by culturing YF virus in chicken embryos and adding substances like sorbitol and gelatin as stabilizers. Although there have been a few subsequent tweaks to the manufacturing process, the two substrains used to make yellow fever vaccines today both date back to work carried out by the Rockefeller Institute during World War II.

In the U.S., the only FDA-licensed YF vaccine is Sanofi Pasteur’s YF-Vax. However, YF-Vax is currently out of stock, so the FDA has temporarily approved the use of Sanofi’s other YF vaccine, Stamaril—the one that sent the BBC reporter into psychosis. When Sanofi’s head of vaccination innovation was asked about adverse events, he “admitted…that the vaccine hadn’t been reviewedin many years.”

The attention-getting reports of fatalities following YF vaccination “have provoked interest in developing a safer YF vaccine that can be easily scaled up to meet…increased global demand.” Researchers in the U.S. and Brazil think they have found the answer, proposing a genetically engineered (recombinant) vaccine produced using tobacco-based “molecular farming.” Thus far, trials of such vaccines have demonstrated inferior efficacy compared to the live-attenuated vaccines, prompting researchers to speculate on the need to include powerful adjuvants. It remains to be seen whether a tobacco-grown vaccine with strong adjuvants, that could usher in a host of other problems, will prove to be an improvement over the troubling live vaccines currently in use.

The viewpoints expressed here do not necessarily represent those of Infowars.

Inside sources have revealed to Alex Jones that the production crew of Empire is under FBI investigation. Alex Jones calls in from the road to blow the lid on this epic scoop.

Source: InfoWars

0 0

Ostrich, rodent on the menu as Cuba seeks food miracle

A flock of ostriches is seen at a farm on the outskirts of Havana
A flock of ostriches is seen at a farm on the outskirts of Havana, Cuba April 11, 2019. REUTERS/Fernando Medina

April 11, 2019

By Sarah Marsh

HAVANA (Reuters) – From breeding miniature cows to importing water buffalo, Cuban leaders have long gotten creative in their effort to remedy food shortages. Now, they are proposing ostrich and rodent farms as an answer, prompting ridicule from a weary population.

Meat and eggs have become hard to find in the Communist-run country in recent months due to a declining economy. Meanwhile officials are touting the potential of the flightless African bird and the hutia, a rodent native to Cuba that can weigh up to 8.5 kg (19 pounds).

“An ostrich lays 60 eggs, and of those you get around 40 chicks, and from these 40 chicks per year you get four tonnes of meat – whereas a cow just gives birth to one calf and after a year it’s only a yearling,” said Guillermo Garcia Frias.

Garcia Frias, 91, holds the honorary title of commander of the revolution as a former guerrilla in Cuba’s 1959 revolution and heads state company Flora and Fauna that is developing seven ostrich farms. He spoke at a roundtable discussion broadcast on state TV last week.

He lavished praise on hutias for their “level of protein higher than any other meat” and “high quality pelt,” noting his company was also breeding crocodiles.

His comments have prompted sarcastic memes and jokes that have gone viral on social media since Cuba’s food schemes have often failed to fulfill expectations.

In one meme, a Cuban arrives home with a live ostrich he got via the state ration card. In another a flock of the birds from Cuba arrives at the Mexican-U.S. border seeking asylum.

Cubans also joked the state might give them an ostrich per household, as it did with chickens during the deep economic depression of the 1990s following the fall of former benefactor the Soviet Union.

“They should be focusing on chicken, a basic foodstuff that has disappeared, rather than something so unusual,” said Elizabeth Perez, 22, a law student who said she hadn’t been able to find chicken in the supermarket for a month.

Ostriches are already farmed around the world, particularly in South Africa. In the United States, the bird is often served more as a novelty than a staple. The red meat is said to resemble lean beef, with a gamey flavor.

For some, Garcia Frias’ comments recalled late leader Fidel Castro’s genetic engineering project to produce high-yield dairy cows.

His cow Ubre Blanca or White Udder is in the Guinness Book of Records for the highest milk yield by a cow in one day: 110 liters (29 gallons). Her offspring were not as productive so the experiment petered out.

Cuba imports 60 to 70 percent of its food because of inefficient central planning of the state-run economy and the effect of the decades-old U.S. trade embargo.

But the country has also had to cut back on imports over the past three years due to cash shortfalls resulting from problems with its deals with former and current leftist allies, in particular declining aid from crisis-stricken Venezuela.

Whenever chicken arrives at supermarkets in Havana these days, long queues quickly form and do not peter out until the stock is exhausted.

Communist Party leader Raul Castro on Wednesday warned the economic situation could worsen in coming months as the United States further tightens its sanctions on the island although it would not become as dire as in the 1990s.

(Reporting by Sarah Marsh; Editing by Cynthia Osterman)

Source: OANN

0 0

French police kill suspect after knife attack in Marseille

Officials in the French city of Marseille say a knife-wielding man has been shot dead after he allegedly attacked several people on a major street.

French media report at least two pedestrians were injured in the knife attack that took place late Tuesday afternoon, but none of their lives were considered to be in danger.

An official with the regional administration said there was no reason yet to think the attack was terror-related but information was sketchy.

The official could not confirm the identity of the attacker or the nature of the attack. The official spoke on condition of anonymity, citing department policy.

Source: Fox News World

0 0

Potential U.S. auto tariffs would hurt Germany, Japan, Korea: Moody’s

Imported automobiles are parked in a lot at the port of Newark New Jersey
Imported automobiles are parked in a lot at the port of Newark New Jersey, U.S., February 19, 2019. REUTERS/Eduardo Munoz

April 9, 2019

(Reuters) – Ratings firm Moody’s said on Tuesday that potential auto tariffs by the United States would be a risk to global growth, hindering economic momentum in Germany, Japan and Korea.

However, such a move would be less severe for China as Chinese vehicle exports were already subject to trade restrictions, Moody’s said in a report, adding that it would also be broadly credit negative for the global auto industry.

“Auto trade restrictions would cause a broader hit to business and consumer confidence globally in an already slowing global economy,” Moody’s Associate Managing Director Elena Duggar wrote.

(Reporting by Philip George in Bengaluru)

Source: OANN

NOW ON AIR
Now On Air

Story Time

1:00 am 6:00 am



The Wider Image: China's start-ups go small in age of 'shoebox' satellites
LinkSpace’s reusable rocket RLV-T5, also known as NewLine Baby, is carried to a vacant plot of land for a test launch in Longkou, Shandong province, China, April 19, 2019. REUTERS/Jason Lee

April 26, 2019

By Ryan Woo

LONGKOU, China (Reuters) – During initial tests of their 8.1-metre (27-foot) tall reusable rocket, Chinese engineers from LinkSpace, a start-up led by China’s youngest space entrepreneur, used a Kevlar tether to ensure its safe return. Just in case.

But when the Beijing-based company’s prototype, called NewLine Baby, successfully took off and landed last week for the second time in two months, no tether was needed.

The 1.5-tonne rocket hovered 40 meters above the ground before descending back to its concrete launch pad after 30 seconds, to the relief of 26-year-old chief executive Hu Zhenyu and his engineers – one of whom cartwheeled his way to the launch pad in delight.

LinkSpace, one of China’s 15-plus private rocket manufacturers, sees these short hops as the first steps towards a new business model: sending tiny, inexpensive satellites into orbit at affordable prices.

Demand for these so-called nanosatellites – which weigh less than 10 kilograms (22 pounds) and are in some cases as small as a shoebox – is expected to explode in the next few years. And China’s rocket entrepreneurs reckon there is no better place to develop inexpensive launch vehicles than their home country.

“For suborbital clients, their focus will be on scientific research and some commercial uses. After entering orbit, the near-term focus (of clients) will certainly be on satellites,” Hu said.

In the near term, China envisions massive constellations of commercial satellites that can offer services ranging from high-speed internet for aircraft to tracking coal shipments. Universities conducting experiments and companies looking to offer remote-sensing and communication services are among the potential domestic customers for nanosatellites.

A handful of U.S. small-rocket companies are also developing launchers ahead of the expected boom. One of the biggest, Rocket Lab, has already put 25 satellites in orbit.

No private company in China has done that yet. Since October, two – LandSpace and OneSpace – have tried but failed, illustrating the difficulties facing space start-ups everywhere.

The Chinese companies are approaching inexpensive launches in different ways. Some, like OneSpace, are designing cheap, disposable boosters. LinkSpace’s Hu aspires to build reusable rockets that return to Earth after delivering their payload, much like the Falcon 9 rockets of Elon Musk’s SpaceX.

“If you’re a small company and you can only build a very, very small rocket because that’s all you have money for, then your profit margins are going to be narrower,” said Macro Caceres, analyst at U.S. aerospace consultancy Teal Group.

“But if you can take that small rocket and make it reusable, and you can launch it once a week, four times a month, 50 times a year, then with more volume, your profit increases,” Caceres added.

Eventually LinkSpace hopes to charge no more than 30 million yuan ($4.48 million) per launch, Hu told Reuters.

That is a fraction of the $25 million to $30 million needed for a launch on a Northrop Grumman Innovation Systems Pegasus, a commonly used small rocket. The Pegasus is launched from a high-flying aircraft and is not reusable.

(Click https://reut.rs/2UVBjKs to see a picture package of China’s rocket start-ups. Click https://tmsnrt.rs/2GIy9Bc for an interactive look at the nascent industry.)

NEED FOR CASH

LinkSpace plans to conduct suborbital launch tests using a bigger recoverable rocket in the first half of 2020, reaching altitudes of at least 100 kilometers, then an orbital launch in 2021, Hu told Reuters.

The company is in its third round of fundraising and wants to raise up to 100 million yuan, Hu said. It had secured tens of millions of yuan in previous rounds.

After a surge in fresh funding in 2018, firms like LinkSpace are pushing out prototypes, planning more tests and even proposing operational launches this year.

Last year, equity investment in China’s space start-ups reached 3.57 billion yuan ($533 million), a report by Beijing-based investor FutureAerospace shows, with a burst of financing in late 2018.

That accounted for about 18 percent of global space start-up investments in 2018, a historic high, according to Reuters calculations based on a global estimate by Space Angels. The New York-based venture capital firm said global space start-up investments totaled $2.97 billion last year.

“Costs for rocket companies are relatively high, but as to how much funding they need, be it in the hundreds of millions, or tens of millions, or even just a few million yuan, depends on the company’s stage of development,” said Niu Min, founder of FutureAerospace.

FutureAerospace has invested tens of millions of yuan in LandSpace, based in Beijing.

Like space-launch startups elsewhere in the world, the immediate challenge for Chinese entrepreneurs is developing a safe and reliable rocket.

Proven talent to develop such hardware can be found in China’s state research institutes or the military; the government directly supports private firms by allowing them to launch from military-controlled facilities.

But it’s still a high-risk business, and one unsuccessful launch might kill a company.

“The biggest problem facing all commercial space companies, especially early-stage entrepreneurs, is failure” of an attempted flight, Liang Jianjun, chief executive of rocket company Space Trek, told Reuters. That can affect financing, research, manufacturing and the team’s morale, he added.

Space Trek is planning its first suborbital launch by the end of June and an orbital launch next year, said Liang, who founded the company in late 2017 with three other former military technical officers.

Despite LandSpace’s failed Zhuque-1 orbital launch in October, the Beijing-based firm secured 300 million yuan in additional funding for the development of its Zhuque-2 rocket a month later.

In December, the company started operating China’s first private rocket production facility in Zhejiang province, in anticipation of large-scale manufacturing of its Zhuque-2, which it expects to unveil next year.

STATE COMPETITION

China’s state defense contractors are also trying to get into the low-cost market.

In December, the China Aerospace Science and Industry Corp (CASIC) successfully launched a low-orbit communication satellite, the first of 156 that CASIC aims to deploy by 2022 to provide more stable broadband connectivity to rural China and eventually developing countries.

The satellite, Hongyun-1, was launched on a rocket supplied by the China Aerospace Science and Technology Corp (CASC), the nation’s main space contractor.

In early April, the China Academy of Launch Vehicle Technology (CALVT), a subsidiary of CASC, completed engine tests for its Dragon, China’s first rocket meant solely for commercial use, clearing the path for a maiden flight before July.

The Dragon, much bigger than the rockets being developed by private firms, is designed to carry multiple commercial satellites.

At least 35 private Chinese companies are working to produce more satellites.

Spacety, a satellite maker based in southern Hunan province, plans to put 20 satellites in orbit this year, including its first for a foreign client, chief executive Yang Feng told Reuters.

The company has only launched 12 on state-produced rockets since the company started operating in early 2016.

“When it comes to rocket launches, what we care about would be cost, reliability and time,” Yang said.

(Reporting by Ryan Woo; Additional reporting by Beijing newsroom; Editing by Gerry Doyle)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
German drug and crop chemical maker Bayer holds annual general meeting
Werner Baumann, CEO of German pharmaceutical and chemical maker Bayer AG, attends the annual general shareholders meeting in Bonn, Germany, April 26, 2019. REUTERS/Wolfgang Rattay

April 26, 2019

By Patricia Weiss and Ludwig Burger

BONN (Reuters) – Bayer shareholders vented their anger over its stock price slump on Friday as litigation risks mount from the German drugmaker’s $63 billion takeover of seed maker Monsanto.

Several large investors said they will not support aspirin investor Bayer’s management in a key vote scheduled for the end of its annual general meeting.

Bayer’s management, led by chief executive Werner Baumann, could see an embarrassing plunge in approval ratings, down from 97 percent at last year’s AGM, which was held shortly before the Monsanto takeover closed in June.

A vote to ratify the board’s actions features prominently at every German AGM. Although it has no bearing on management’s liability, it is seen as a key gauge of shareholder sentiment.

“Due to the continued negative development at Bayer, high legal risks and a massive share price slump, we refuse to ratify the management board and supervisory board’s actions during the business year,” Janne Werning, representing Germany’s Union Investment, a top-20 shareholder, said in prepared remarks.

About 30 billion euros ($34 billion) have been wiped off Bayer’s market value since August, when a U.S. jury found the pesticide and drugs group liable because Monsanto had not warned of alleged cancer risks linked to its weedkiller Roundup.

Bayer suffered a similar defeat last month and more than 13,000 plaintiffs are claiming damages.

Bayer is appealing or plans to appeal the verdicts.

Deutsche Bank’s asset managing arm DWS said shareholders should have been consulted before the takeover, which was agreed in 2016 and closed in June last year.

“You are pointing out that the lawsuits have not been lost yet. We and our customers, however, have already lost something – money and trust,” Nicolas Huber, head of corporate governance at DWS, said in prepared remarks for the AGM.

He said DWS would abstain from the shareholder vote of confidence in the executive and non-executive boards.

Two people familiar with the situation told Reuters this week that Bayer’s largest shareholder, BlackRock, plans to either abstain from or vote against ratifying the management board’s actions.

Asset management firm Deka, among Bayer’s largest German investors, has also said it would cast a no vote.

Baumann said Bayer’s true value was not reflected in the current share price.

“There’s no way to make this look good. The lawsuits and the first verdicts weigh heavily on our company and it’s a concern for many people,” he said, adding it was the right decision to buy Monsanto and that Bayer was vigorously defending itself.

This month, shareholder advisory firms Institutional Shareholder Services (ISS) and Glass Lewis recommended investors not to give the executive board their seal of approval.

(Reporting by Patricia Weiss and Ludwig Burger; Editing by Alexander Smith)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

Sudan’s military, which ousted President Omar al-Bashir after months of protests against his 30-year rule, says it intends to keep the upper hand during the country’s transitional period to civilian rule.

The announcement is expected to raise tensions with the protesters, who demand immediate handover of power.

The Sudanese Professionals Association, which is spearheading the protests, said Friday the crowds will stay in the streets until all their demands are met.

Shams al-Deen al-Kabashi, the spokesman for the military council, said late Thursday that the military will “maintain sovereign powers” while the Cabinet would be in the hands of civilians.

The protesters insist the country should be led by a “civilian sovereign” council with “limited military representation” during the transitional period.

The army toppled and arrested al-Bashir on April 11.

Source: Fox News World

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
FILE PHOTO: Small toy figures are seen in front of a displayed Huawei and 5G network logo in this illustration picture
FILE PHOTO: Small toy figures are seen in front of a displayed Huawei and 5G network logo in this illustration picture, March 30, 2019. REUTERS/Dado Ruvic

April 26, 2019

By Charlotte Greenfield

WELLINGTON (Reuters) – China’s Huawei Technologies said Britain’s decision to allow the firm a restricted role in building parts of its next-generation telecoms network was the kind of solution it was hoping for in New Zealand, where it has been blocked from 5G plans.

Britain will ban Huawei from all core parts of 5G network but give it some access to non-core parts, sources have told Reuters, as it seeks a middle way in a bitter U.S.-China dispute stemming from American allegations that Huawei’s equipment could be used by Beijing for espionage.

Washington has also urged its allies to ban Huawei from building 5G networks, even as the Chinese company, the world’s top producer of telecoms equipment, has repeatedly said the spying concerns are unfounded.

In New Zealand, a member of the Five Eyes intelligence sharing network that includes the United States, the Government Communications Security Bureau (GCSB) in November turned down an initial request from local telecommunication firm Spark to include Huawei equipment in its 5G network, but later gave the operator options to mitigate national security concerns.

“The proposed solution in the UK to restrict Huawei from bidding for the core is exactly the type of solution we have been looking at in New Zealand,” Andrew Bowater, deputy CEO of Huawei’s New Zealand arm, said in an emailed statement.

Spark said it has noted the developments in Britain and would raise it with the GCSB.

The reports “suggest the UK is following other European jurisdictions in taking a considered and balanced approach to managing supplier-related security risks in 5G”, Andrew Pirie, Spark’s corporate relations lead, said in an email.

“Our discussions with the GCSB are ongoing and we expect that the UK developments will be a further item of discussion between us,” Pirie added.

New Zealand’s minister for intelligence services, Andrew Little, did not immediately respond to a request for comment.

British culture minister Jeremy Wright said on Thursday that he would report to parliament the conclusions of a government review of the 5G supply chain once they had been taken.

He added that the disclosure of confidential discussions on the role of Huawei was “unacceptable” and that he could not rule out a criminal investigation into the leak.

The decisions by Britain and Germany to use Huawei gear in non-core parts of 5G network makes it harder to prove Huawei should be kept out of New Zealand telecommunication networks, said Syed Faraz Hasan, an expert in communication engineering and networks at New Zealand’s Massey University

He pointed out Huawei gear was already part of the non-core 4G networks that 5G infrastructure would be built on.

“Unless there is a convincing argument against the Huawei devices … it is difficult to keep them away,” Hasan said.

(Reporting by Charlotte Greenfield; Editing by Himani Sarkar)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
FILE PHOTO: The logo commodities trader Glencore is pictured in Baar
FILE PHOTO: The logo of commodities trader Glencore is pictured in front of the company’s headquarters in Baar, Switzerland, July 18, 2017. REUTERS/Arnd Wiegmann

April 26, 2019

(Reuters) – Glencore shares plunged the most in nearly four months on Friday after news overnight that U.S. regulators were investigating whether the miner broke some rules through “corrupt practices”.

Shares of the FTSE 100 company fell as much as 4.2 percent in early deals, and were down 3.5 percent at 310.25 pence by 0728 GMT.

On Thursday, Glencore said the U.S. Commodity Futures Trading Commission is investigating whether the company and its units have violated some provisions of the Commodity ExchangeAct and/or CFTC Regulations.

(Reporting by Muvija M in Bengaluru)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
Current track

Title

Artist